Background: A vast body of literature has documented regional variations in healthcare utilization rates. The extent to which such variations are "unwarranted" critically depends on whether there are corresponding variations in patients' needs. Using a unique medical registry, the current paper investigated any associations between utilization rates and patients' needs, as measured by two patient-reported outcome measures (PROMs).
Background
Systematic variations in the utilization rates of healthcare services are well established and apparent in all developed healthcare systems [1, 2] . Variations are not inherently bad, and variations due to fluctuations in patients' need for treatment are considerd as warranted variations. However, empirical findings demonstrate how they result from factors unrelated to patients' need for treatmenti.e. unwarranted variations [3] . Based on aggregate data, earlier studies demonstrated how healthcare services exhibit diminishing returns [4] [5] [6] , a phenomenon commonly known as "flat of the curve" [7] . However, evidence for specific conditions is scarce.
Wennberg suggested a framework for analysis of variation in population based treatment rates that has been widely adopted [8] . The framework categorized variation as being present in either (i) "effective care," (ii) "preference-sensitive care," and (iii) "supply-sensitive care". Effective care refers to interventions with few treatment options, for which benefits far outweigh risk and the optimal rate of utilization is 100% of patients who need treatment according to evidence-based guidelines. Care is deemed preference-sensitive when diagnostic test results are open to interpretation and two or more generally accepted treatment options are available. Variations will reflect systematic differences in patients' or physicians' preferences. Supply-sensitive care comprises activities for which the frequency of use depends on the capacity of the local healthcare system (e.g., hospital beds, diagnostic equipment, or physicians). At an aggregate level, variations in surgery for degenerative disorders of the spine might exchibit variation from all three categories.
Patients with degenerative disorders of the spine report significant reduction in health-related quality of life (HRQoL). Low back and neck pain and are the largest contributors to health loss in Norway [9] . Such disorders represent the largest single cause of sick leave worldwide (11% in Norway, estimated social cost of 1-1.6 billion euro) [10, 11] . These disorders can be treated conservatively or with surgery. In some cases surgery is clearly effective [12] , but preferences and supply sensitivity may explain why treatment rates differ.
Related studies, considering the association between patients' need and treatment rates tend to use mortality or readmission rates [13] [14] [15] . Although such measures are objective, easily obtainable, and arguably can be used as a proxy for health or quality of care, they are inadequate when considering variations in specific elective treatments where unwarranted variations are likely to excist [16] . Further, they do not reflect patients' need for treatment. When patients' need is not a matter of either/ or, but rather of different degrees, a continuous assessment of health is more suitable, whereby patients report their level of discomfort using patient-reported outcome measures (PROMs). This paper considered HRQoL at baseline and posttreatment in relation to treatment rates. Our unique dataset was retreived from both administrative and medical registries for patients who underwent surgery for lumbar disc herniation (LDH) or lumbar spinal stenosis (LSS). A sample representative of the treated population demonstrates how need (i.e., "ill health" and "capacity to benefit") varied across hospital regions. We show how such differences are associate with regional variation in treatment rates.
Under Norway's public health insurance scheme, patients are eligible for free specialized care and surgeons are instructed to prioritize care in accordance with official guidelines. Hence, preference or supply should reflect both regional treatment rates and patients' health. The hypothesis presented here is simply: in regions with high (low) treatment rates, surgeons' perceived threshold for treatment is lower (higher). Thus, patients treated in high rate regions should have better health at baseline and smaller health gains after treatment. Such a relation would suggest evidence of unwarranted variations. Accordingly, the aim of this study is to explore whether the "flat of the curve" phenomenon is present in lumbar spine surgery, and, if demonstrated, to quantify it.
Methods
Our analysis was based on three linked data sets, collected between 2010 and 2015: administrative registry data from the Norwegian patient registry (NPR), medical registry data from the Norwegian registry for spine surgery (NORspine), and information about patients' education level from Statistics Norway (SSB). NPR contains information on all patients who have received government-financed specialized care. By law, the NPR is exempt from requiring informed consent at registration.
Data collection in NORspine
NORspine is a comprehensive medical registry for quality control and research. It receives funding from the government and has no ties to industry. All patients undegoing surgery for degenerative disorders in the lumbar spine are invited to participate in the registry, and consent forms are obtained from all participants. In 2015, NORspine comprised 38 of 40 (93%) public and private hospitals performing surgery for degenerative disorders in the lumbar spine. The case completeness rate was 63% [17] .
Upon admission for surgery, patients completed a baseline questionnaire on demographics, lifestyle, and patient-reported HRQoL. During the hospital stay, the surgeon used a standard registration form to record data on diagnosis, treatment, and comorbidity. At 3 and 12 months post-surgery, patients received questionnaire similar to the one completed at baseline via regular post, completed it at home, and returned it in pre-stamped envelopes to the central registry unit. Nonrespondents received one reminder that included a new copy of the questionnaire.
The NORspine protocol has been approved by the Data Inspectorate of Norway. It handled all registration at follow-up without involvement from the treating institution. All patients were granted treatment before answering the questionnaire, and they had no incentive to over-or under-report their true health condition.
Patient-reported outcome measure
NORspine contains two PROM instruments: the generic EuroQol with 5 dimensions (EQ-5D) and the diseasespecific Oswestry Disability Index (ODI). The EQ-5D version used in NORspine describes each dimension along one of 3 levels, yielding 243 possible health-state combinations that are assigned health-state values derived from a population sample in the United Kingdom [18] .
The ODI (version 2.1a) includes 10 questions about the limitations of daily living activities. Each item is rated from 0 to 5 and then summarized into a total percentage score ranging from 0 (none) to 100 (maximum pain-related disability) [19] . In the absence of PROM at 12 months, we used last observed carried forward (PROM at 3 months).
Inclusion, exclusion, and merging
Defined by a selection algorithm developed by NORspine, the sample obtained from NPR was based on diagnosis codes (ICD-10) in combination with procedure codes (NCSP). It included all patients who received publicly-funded surgery for LDH or LSS within our time frame (36,378 observations).
NORspine excludes patients who are: unable or unwilling to submit information; under 16 years of age; have documented drug abuse, severe psychiatric disorders, traumatic or infectious conditions, or; tumors involving the spine. We used NORspine criteria to exclude 860 patients from the NPR sample. Hence, we calculated treatment rates based on 35,518 treatments.
Registries were merged based on hospital admission date and an encrypted version of an 11-digit personal identification number. Among 22,577 observations from NORspine, we were unable to match 3284 observations with NPR, largely because NORspine also contains observations on treatments financed out of pocket or by private insurance, which are not part of NPR. We were able to match 19,293 of the observations from NORspine with NPR. After matching, we omitted all observations with missing values for EQ-5D at baseline (1598), smoker status (169), labor market affiliation (315), BMI (944), previous surgery (268), and duration of symptoms (710). The matching proces is illustrated by Fig. 1 . Our analysis was based on 15,810 observations (8120 LDH and 7690 LSS).
Covariates
For statistical estimation, we selected covariates thought to affect patients HRQoL at baseline and health gain. ; own hospital service area); regional effects (19 regions); and time-trend (1:6).
When estimating health gain, we also included duration of hospital stay (days, count). For simplicity, the results reported here include only the coefficients for treatment rates, with health measured by EQ-5D (see Appendix Table A2 and A3 for all coefficients).
Analysis
We used direct standardization to calculate population treatment rates per 10,000, using publicly available data from SSB to adjust for gender and age composition in each of the 428 Norwegian municipalities.
We used a general estimating equation (GEE) to estimate the relationship between patients' health and treatment rates [20] . This allowed us to adjust health for individual patient characteristics, account for clustering within regions, and estimate a global effect. We considered using other random-or fixed-effect models, but concluded that a GEE would yield more robust estimates due to data distribution and an unknown correlation structure. To find the best fit for the model, we tested the standard functional forms (linear, polynomials, exponential, and logarithmic). For treatment rates, we used partial derivatives to estimate the marginal effects.
While there is no standardized way to measure the goodness of fit for a GEE model, we applied the method suggested by Zheng [21] in calculating the R 2 marg . We estimated the model with an independence correlation structure and a Gaussian link function. As part of the sensitivity analysis, we excluded patients who received emergency treatment, using only EQ-5D reported at 3 months, or estimated the model using ODI (see Appendix). We conducted the same analysis using regional effects as a random intercept. The association between health and treatment rates concurred with the GEE model, with comparable effect measures. When including regional dummy-variables in a fixed effects model, the results were similar to those in the GEE. Other sensitivity analysis included only regions with a NORspine response rate higher than 20, 30%, or 40%. All sensitivity test results reported here were consistent. All estimations were conducted using R 3.4.0 software (https:// www.r-project.org/).
Results
Variation in health and utilization rates Table 1 presents the regions in ascending order with regard to mean annual treatment rates, followed by the NORspine response rate. Subsequent columns show median EQ-5D values at baseline and health gain. Additional file 1: Table  A1 in appendix shows the statistics of covariates.
From Table 1 , we computed a variation coefficient by dividing the sum of the three highest rates by the sum of the three lowest rates. The aggregate variation coefficient was 1.85. Considering each year independently, the coefficient ranged from 2.39 (in 2010) to 1.74 (in 2014). The widest range of treatment rates (20.4 in Nord-Trondelag and 6.3 in Telemark) occured in 2010.
At baseline, median EQ-5D varied from 0.159 to 0.364 (interquartile range = 0.053). When considering EQ-5D health gain, the median scores varied from 0.14 to 0.413 (interquartile range = 0.120). Using ANOVA (F-value) and Kurskal-Wallis test (χ 2 value), we found significant variation in EQ-5D between the groups, both at baseline (F = 7,16, χ 2 = 132,29) and health gain (F = 7,91, χ 2 = 131,08). Figure 2 shows the distribution of unadjusted EQ-5D scores, the distribution for EQ-5D at baseline, and EQ-5D health gain. Even visual inspection of unadjusted EQ-5D scores showed a small but consistent difference in health between the grouped regions. The high-rate regions treated healthier patients and had consistently lower health gains. Table 2 presents the output of the GEE estimation, with significance based on robust standard errors. Linear terms and square roots yielded the best fit of all models. At baseline, we found a positive correlation between EQ-5D and treatment rates, indicating that the average patient was healthier at the time of treatment as treatment rates increased.
Model output
We observed a negative correlation between health gain and treatment rates. Thus, patients' average health gain decreased as treatment rates increased. Figure 3 depicts the marginal effect of treatment rates on EQ-5D. Naturally, the marginal effect from the linear models are constant. For the nonlinear model estimating EQ-5D at baseline, better health was associated with increases in treatment rates, but at a decreasing rate. Similarly, for the marginal effect of treament rates on health gain, increased treatment rates were associated with lower health gain, but at a decreasing rate.
Consequently, given equal patient population characteristics, the EQ-5D baseline score of a patient living in a region with a treatment rate of 8 per 10,000 likely would be 0.024 higher on average, compared to a patient treated in a region with a treatment rate of 18 per 10, 000. Given the same two rates, patients in the high-rate region would on average experience 0.044 lower EQ-5D gains than patients in the low-rate region. If we consider the same measures based on ODI, there is no difference at baseline, while the difference in health gain between regions treating 8 or 18 per 10,000 would be 16.31 (See appendix Table A3 ).
Discussion
This study shows that, on average, higher treatment rates are associated with better health at baseline and lower health gains. This indicates that unwarranted variations occur in surgical treatment for degenerative lumbar spine disorders, independently of whether we define need as ill health or capacity to benefit. The effect size is moderate, but large enough to display statistically significant contrasts in the mean health of the patients, hence, the marginal effect on a patient level is therefore considerably larger.
The results suggest that patients face different barriers to care, depending on their place of residence. In high rate regions, the average patient's baseline health is better, and their health gains are lower, confirming the "flat of the curve-phenomenon" The variation is in conflict with a longstanding egalitarian Norwegian health policy, which has 'equal access for equal need' as one of it's specific goals. Place of residence is explicitly stated a factors that should not influence access to health care [21] . Varagunam et al. [2015] considered the relationship between EQ-5D and disease specific PROMS with surgeon volumes for three elective surgeries but found no significant effects [22] . Rachet Jacquet et al.
[2019] considered the causal link between hospital volume and patient outcome in hip fractures, and found small but not clinically significant effects [23] . In contrast, the present study considers the population perspective, not the physician perspective. To the best of our knowledge, no previous large-scale studies studies provide the level of detailed HRQoL measures from a population perspective, as we do here. Keller et al. [1999] determined that the concave relationship between treatment rates for LDH affect EQ-5D, both at baseline and health gain [24] . However, that cross-sectional study included only three regions in a US system, with fewer than 500 Returning to Wennbergs' three categories of care, when the presence and duration of symptoms are consistent with clinical and imaging findings, there is a high degree of consensus in the medical community about treatment decisions, and patients experience large health gains. Hence, if only such patients were treated, the treatments would likely reflect "effective care". However, when a patient presents with unspecific symptoms, not obviously consistent with clinical and imaging findings, there might be an ambiguity among specialist about whether or not invasive treatment is beneficial. Table A1 shows large variations in case mix across regions, and Tables A2 and A3 depict how socioeconomic, lifestyle, and clinical factors predict both health at baseline and health gains (Appendix). Education, labor market affiliation, smoking, and body mass index vary markedly in the patient population between regions in our sample. Whether this is an expression of preferences or mirror the general population is unclear. In any case, better knowledge about whether physicians should consider lifestyle factors when considering treatment options, might lead to more similar decision-making processes and reduction of unwarranted variation. Such ambiguity is also present in primary care, and reflected in the rate of patients who are reffered to diagnostic imaging [25] .
Due to crowding out effects (a surgeon can only treat one patient at the time), it is impossible to estimate the fraction of variations related to supply effects, without first knowing all activity in a hospital. Even then, it is questionable what yardstick one would use to produce a correct meassure of supplyi.e. surgeons, beds, staff, operation rooms etc. However, it is not unlikely that some of the variation we observe is caused by such supply effects.
Our data do not allow analysis of differences in physicians preferences versus differences in supply as possible causes for the observed regional variation in utilization rates. Variation in preferences are cultural phenomenons, as physicians are quick to adapt their behavior to the enviroment they operate in [26] . Possible approaches to reduce such variation include peer review of practice patterns, such as clinical audits, educational initiatives, development of standardized decision support and leverage of economical incentives, such as the reimbursment per procedure [27] . On the other hand, differences in capacity, such as the number of spine surgeons per population, or surgeons availablity to operating rooms, may cause variation. Possible approaches to reduction of such variation include leadership engagement and action, such as staff recruitment or reduction, and changes in priority between surgical specialties in allocation of operating room capacity. We suggest that comprehensive multi-level analysis of registry data to identify factors associated with variation both on the individual level (patients and surgeons) and group-level, including clustering within units at higher levels (municipalitities, Fig. 3 Plotting treatment rates marginal effect on EQ-5D. The two red curves represents EQ-5D at baseline, black curves represents EQ-5D health gain. Stapeled curves are linear models, solid are non-linear models hospitals and health trusts) is necessary to address specific causes for unwarranted variation. Stricter clinical guidelines about indications for surgey and implemeting clinically relevant performance metrics for value-based health care have been suggested to reduce the number of unneccessary and inefficient surgical procedures [28, 29] .
Strengths and weaknesses
The analysis reported here is based on data that is representative for the treated population. Furthermore, our generic and disease-specific HRQoL both yielded similar results.
Range of sensitivity testing did not affect our results. The data do not contain full information on EQ-5D at follow-up. However, a loss to follow-up study found no difference in health between respondents and nonrespondents [30] .
Future studies of this subject should include data on the number of patients on waiting lists for treatments, alternatively how long patients waited before receiving care. By inclusion of such data in the analysis, patient specific marginal effects can be estimated. These data were not available for the current study.
Conclusion
The analysis presented here shows a clear association between increasing treatment rates and better health at baseline, and furthermore, lower health gains, indicating unwarranted wariaions. Our findings confirm the"flat of the curve"-phenomenon on regional basis, indicating conflicts with the Norwegian egalitarian health policy.
